The role and effects of glucocorticoid-induced leucine zipper in the context of inflammation resolution

Journal of Immunology

Volumn 194, Issue 10, 2015, Pages 4940-4950

  Vago, Juliana P ^a   Tavares, Luciana P ^a   Garcia, Cristiana C ^a,b   Lima, Kátia M ^a   Perucci, Luiza O ^a   Vieira, Érica L ^a   Nogueira, Camila R C ^a   Soriani, Frederico M ^a   Martins, Joilson O ^c   Silva, Patrícia M R ^b   Gomes, Karina B ^a   Pinho, Vanessa ^a   Bruscoli, Stefano ^d   Riccardi, Carlo ^d   Beaulieu, Elaine ^e   Morand, Eric F ^e   Teixeira, Mauro M ^a   Sousa, Lirlândia P ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSITY OF PERUGIA   (Italy)

^e MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CASPASE; CYTOKINE; DEXAMETHASONE; GLUCOCORTICOID; GLUCOCORTICOID INDUCED LEUCINE ZIPPER PROTEIN; HYBRID PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOCORTIN 1; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PEPTIDE; PROTEIN MCL 1; REGULATOR PROTEIN; TRANSACTIVATOR OF TRANSCRIPTION PEPTIDE; UNCLASSIFIED DRUG; DSIP1 PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; INFLAMMATION; MACROPHAGE; MALE; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NEUTROPHILIC INFLAMMATION; NONHUMAN; PHENOTYPE; PLEURISY; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SURVIVAL; TREATMENT RESPONSE; ANIMAL; BAGG ALBINO MOUSE; CELL MOTION; DISEASE MODEL; FLOW CYTOMETRY; IMMUNOLOGY; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; ANNEXIN A1; APOPTOSIS; BLOTTING, WESTERN; CELL MOVEMENT; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; INFLAMMATION; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MICE; MICE, INBRED BALB C; PLEURISY; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS;

EID: 84929120005     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1401722     Document Type: Article

References (50)

1. Serhan, C. N., S. D. Brain, C. D. Buckley, D. W. Gilroy, C. Haslett, L. A. O'Neill, M. Perretti, A. G. Rossi, and J. L. Wallace. 2007. Resolution of inflammation: state of the art, definitions and terms. FASEB J. 21: 325-332.
2. Alessandri, A. L., L. P. Sousa, C. D. Lucas, A. G. Rossi, V. Pinho, and M. M. Teixeira. 2013. Resolution of inflammation: mechanisms and opportunity for drug development. Pharmacol. Ther. 139: 189-212.
3. Sousa, L. P., A. L. Alessandri, V. Pinho, and M. M. Teixeira. 2013. Pharmacological strategies to resolve acute inflammation. Curr. Opin. Pharmacol. 13: 625-631.
4. Perretti, M., and F. D'Acquisto. 2009. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat. Rev. Immunol. 9: 62-70.
5. Beaulieu, E., and E. F. Morand. 2011. Role of GILZ in immune regulation, glucocorticoid actions and rheumatoid arthritis. Nat. Rev. Rheumatol. 7: 340-348.
6. Clark, A. R., and M. G. Belvisi. 2012. Maps and legends: the quest for dissociated ligands of the glucocorticoid receptor. Pharmacol. Ther. 134: 54-67.
7. D'Adamio, F., O. Zollo, R. Moraca, E. Ayroldi, S. Bruscoli, A. Bartoli, L. Cannarile, G. Migliorati, and C. Riccardi. 1997. A new dexamethasoneinduced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death. Immunity 7: 803-812.
8. Ayroldi, E., and C. Riccardi. 2009. Glucocorticoid-induced leucine zipper (GILZ): a new important mediator of glucocorticoid action. FASEB J. 23: 3649-3658.
9. Cannarile, L., S. Cuzzocrea, L. Santucci, M. Agostini, E. Mazzon, E. Esposito, C. Muià, M. Coppo, R. Di Paola, and C. Riccardi. 2009. Glucocorticoid-induced leucine zipper is protective in Th1-mediated models of colitis. Gastroenterology 136: 530-541.
10. Beaulieu, E., D. Ngo, L. Santos, Y. H. Yang, M. Smith, C. Jorgensen, V. Escriou, D. Scherman, G. Courties, F. Apparailly, and E. F. Morand. 2010. Glucocorticoid-induced leucine zipper is an endogenous antiinflammatory mediator in arthritis. Arthritis Rheum. 62: 2651-2661.
11. Srinivasan, M., and S. Janardhanam. 2011. Novel p65 binding glucocorticoidinduced leucine zipper peptide suppresses experimental autoimmune encephalomyelitis. J. Biol. Chem. 286: 44799-44810.
12. Esposito, E., S. Bruscoli, E. Mazzon, I. Paterniti, M. Coppo, E. Velardi, S. Cuzzocrea, and C. Riccardi. 2012. Glucocorticoid-induced leucine zipper (GILZ) over-expression in T lymphocytes inhibits inflammation and tissue damage in spinal cord injury. Neurotherapeutics 9: 210-225.
13. Ngo, D., E. Beaulieu, R. Gu, A. Leaney, L. Santos, H. Fan, Y. Yang, W. Kao, J. Xu, V. Escriou, et al. 2013. Divergent effects of endogenous and exogenous glucocorticoid-induced leucine zipper in animal models of inflammation and arthritis. Arthritis Rheum. 65: 1203-1212.
14. Solito, E., A. Kamal, F. Russo-Marie, J. C. Buckingham, S. Marullo, and M. Perretti. 2003. A novel calcium-dependent proapoptotic effect of annexin 1 on human neutrophils. FASEB J. 17: 1544-1546.
15. Vago, J. P., C. R. Nogueira, L. P. Tavares, F. M. Soriani, F. Lopes, R. C. Russo, V. Pinho, M. M. Teixeira, and L. P. Sousa. 2012. Annexin A1 modulates natural and glucocorticoid-induced resolution of inflammation by enhancing neutrophil apoptosis. J. Leukoc. Biol. 92: 249-258.
16. Maderna, P., S. Yona, M. Perretti, and C. Godson. 2005. Modulation of phagocytosis of apoptotic neutrophils by supernatant from dexamethasonetreated macrophages and annexin-derived peptide Ac2-26. J. Immunol. 174: 3727-3733.
17. Dalli, J., C. P. Jones, D. M. Cavalcanti, S. H. Farsky, M. Perretti, and S. M. Rankin. 2012. Annexin A1 regulates neutrophil clearance by macrophages in the mouse bone marrow. FASEB J. 26: 387-396.
18. -/- mouse. FASEB J. 17: 253-255.
19. Montero-Melendez, T., J. Dalli, and M. Perretti. 2013. Gene expression signature-based approach identifies a pro-resolving mechanism of action for histone deacetylase inhibitors. Cell Death Differ. 20: 567-575.
20. Yang, Y. H., D. Aeberli, A. Dacumos, J. R. Xue, and E. F. Morand. 2009. Annexin-1 regulates macrophage IL-6 and TNF via glucocorticoid-induced leucine zipper. J. Immunol. 183: 1435-1445.
21. Sousa, L. P., F. Lopes, D. M. Silva, L. P. Tavares, A. T. Vieira, B. M. Rezende, A. F. Carmo, R. C. Russo, C. C. Garcia, C. A. Bonjardim, et al. 2010. PDE4 inhibition drives resolution of neutrophilic inflammation by inducing apoptosis in a PKA-PI3K/Akt-dependent and NF-kB-independent manner. J. Leukoc. Biol. 87: 895-904.
22. Souza, D. G., C. T. Fagundes, F. A. Amaral, D. Cisalpino, L. P. Sousa, A. T. Vieira, V. Pinho, J. R. Nicoli, L. Q. Vieira, I. M. Fierro, and M. M. Teixeira. 2007. The required role of endogenously produced lipoxin A4 and annexin-1 for the production of IL-10 and inflammatory hyporesponsiveness in mice. J. Immunol. 179: 8533-8543.
23. Bannenberg, G. L., N. Chiang, A. Ariel, M. Arita, E. Tjonahen, K. H. Gotlinger, S. Hong, and C. N. Serhan. 2005. Molecular circuits of resolution: formation and actions of resolvins and protectins. J. Immunol. 174: 4345-4355.
24. Chiang, N., M. Shinohara, J. Dalli, V. Mirakaj, M. Kibi, A. M. Choi, and C. N. Serhan. 2013. Inhaled carbon monoxide accelerates resolution of inflammation via unique proresolving mediator-heme oxygenase-1 circuits. J. Immunol. 190: 6378-6388.
25. Sousa, L. P., A. F. Carmo, B. M. Rezende, F. Lopes, D. M. Silva, A. L. Alessandri, C. A. Bonjardim, A. G. Rossi, M. M. Teixeira, and V. Pinho. 2009. Cyclic AMP enhances resolution of allergic pleurisy by promoting inflammatory cell apoptosis via inhibition of PI3K/Akt and NF-κB. Biochem. Pharmacol. 78: 396-405.
26. De Sousa, L. P., B. S. Brasil, B. M. Silva, M. H. Freitas, S. V. Nogueira, P. C. Ferreira, E. G. Kroon, and C. A. Bonjardim. 2005. Plasminogen/plasmin regulates c-fos and egr-1 expression via the MEK/ERK pathway. Biochem. Biophys. Res. Commun. 329: 237-245.
27. Lichtnekert, J., T. Kawakami, W. C. Parks, and J. S. Duffield. 2013. Changes in macrophage phenotype as the immune response evolves. Curr. Opin. Pharmacol. 13: 555-564.
28. Schif-Zuck, S., N. Gross, S. Assi, R. Rostoker, C. N. Serhan, and A. Ariel. 2011. Saturated-efferocytosis generates pro-resolving CD11b low macrophages: modulation by resolvins and glucocorticoids. Eur. J. Immunol. 41: 366-379.
29. Ariel, A., and C. N. Serhan. 2012. New lives given by cell death: macrophage differentiation following their encounter with apoptotic leukocytes during the resolution of inflammation. Front. Immunol. 3: 4.
30. Morris, J. F., S. Omer, E. Davies, E. Wang, C. John, T. Afzal, S. Wain, J. C. Buckingham, R. J. Flower, and H. C. Christian. 2006. Lack of annexin 1 results in an increase in corticotroph number in male but not female mice. J. Neuroendocrinol. 18: 835-846.
31. Akasheh, R. T., M. Pini, J. Pang, and G. Fantuzzi. 2013. Increased adiposity in annexin A1-deficient mice. PLoS ONE 8: e82608.
32. Yang, Y. H., E. Morand, and M. Leech. 2013. Annexin A1: potential for glucocorticoid sparing in RA. Nat. Rev. Rheumatol. 9: 595-603.
33. Hoppstädter, J., B. Diesel, L. K. Eifler, T. Schmid, B. Brüne, and A. K. Kiemer. 2012. Glucocorticoid-induced leucine zipper is downregulated in human alveolar macrophages upon Toll-like receptor activation. Eur. J. Immunol. 42: 1282-1293.
34. Hahn, R. T., J. Hoppstädter, K. Hirschfelder, N. Hachenthal, B. Diesel, S. M. Kessler, H. Huwer, and A. K. Kiemer. 2014. Downregulation of the glucocorticoid-induced leucine zipper (GILZ) promotes vascular inflammation. Atherosclerosis 234: 391-400.
35. Soehnlein, O., and L. Lindbom. 2010. Phagocyte partnership during the onset and resolution of inflammation. Nat. Rev. Immunol. 10: 427-439.
36. Bystrom, J., I. Evans, J. Newson, M. Stables, I. Toor, N. van Rooijen, M. Crawford, P. Colville-Nash, S. Farrow, and D. W. Gilroy. 2008. Resolutionphase macrophages possess a unique inflammatory phenotype that is controlled by cAMP. Blood 112: 4117-4127.
37. Stables, M. J., S. Shah, E. B. Camon, R. C. Lovering, J. Newson, J. Bystrom, S. Farrow, and D. W. Gilroy. 2011. Transcriptomic analyses of murine resolution-phase macrophages. Blood 118: e192-e208.
38. Dalli, J., and C. N. Serhan. 2012. Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and proresolving mediators. Blood 120: e60-e72.
39. Berrebi, D., S. Bruscoli, N. Cohen, A. Foussat, G. Migliorati, L. Bouchet-Delbos, M. C. Maillot, A. Portier, J. Couderc, P. Galanaud, et al. 2003. Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an antiinflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10. Blood 101: 729-738.
40. Scannell, M., M. B. Flanagan, A. deStefani, K. J. Wynne, G. Cagney, C. Godson, and P. Maderna. 2007. Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages. J. Immunol. 178: 4595-4605.
41. Bereshchenko, O., M. Coppo, S. Bruscoli, M. Biagioli, M. Cimino, T. Frammartino, D. Sorcini, A. Venanzi, M. Di Sante, and C. Riccardi. 2014. GILZ promotes production of peripherally induced Treg cells and mediates the crosstalk between glucocorticoids and TGF-β signaling. Cell Rep. 7: 464-475.
42. Cheng, Q., H. Fan, D. Ngo, E. Beaulieu, P. Leung, C. Y. Lo, R. Burgess, Y. G. van der Zwan, S. J. White, L. M. Khachigian, et al. 2013. GILZ overexpression inhibits endothelial cell adhesive function through regulation of NF-βB and MAPK activity. J. Immunol. 191: 424-433.
43. Pinheiro, I., L. Dejager, I. Petta, S. Vandevyver, L. Puimège, T. Mahieu, M. Ballegeer, F. Van Hauwermeiren, C. Riccardi, M. Vuylsteke, and C. Libert. 2013. LPS resistance of SPRET/Ei mice is mediated by Gilz, encoded by the Tsc22d3 gene on the X chromosome. EMBO Mol. Med. 5: 456-470.
44. L and augmentation of thymocyte apoptosis in GILZ overexpressing transgenic mice. Blood 104: 4134-4141.
45. Delfino, D. V., M. Agostini, S. Spinicelli, C. Vacca, and C. Riccardi. 2006. Inhibited cell death, NF-κB activity and increased IL-10 in TCR-triggered thymocytes of transgenic mice overexpressing the glucocorticoid-induced protein GILZ. Int. Immunopharmacol. 6: 1126-1134.
46. Grugan, K. D., C. Ma, S. Singhal, N. L. Krett, and S. T. Rosen. 2008. Dual regulation of glucocorticoid-induced leucine zipper (GILZ) by the glucocorticoid receptor and the PI3-kinase/AKT pathways in multiple myeloma. J. Steroid Biochem. Mol. Biol. 110: 244-254.
47. Ayroldi, E., O. Zollo, A. Bastianelli, C. Marchetti, M. Agostini, R. Di Virgilio, and C. Riccardi. 2007. GILZ mediates the antiproliferative activity of glucocorticoids by negative regulation of Ras signaling. J. Clin. Invest. 117: 1605-1615.
48. + cells. Oncogene 31: 1419-1430.
49. Jia, Y., E. F. Morand, W. Song, Q. Cheng, A. Stewart, and Y. H. Yang. 2013. Regulation of lung fibroblast activation by annexin A1. J. Cell. Physiol. 228: 476-484.
50. Damazo, A. S., S. Yona, R. J. Flower, M. Perretti, and S. M. Oliani. 2006. Spatial and temporal profiles for anti-inflammatory gene expression in leukocytes during a resolving model of peritonitis. J. Immunol. 176: 4410-4418.